Category: Regions

Design Pharmaceuticals Closes $5 Million Pre-series A Round
April 12, 2022 Off

Design Pharmaceuticals Closes $5 Million Pre-series A Round

By Author

Design Pharmaceuticals, a company redesigning small molecule drug discovery,  has announced the closing of a pre-series A round of $5 million, including an investment of $3 million from Virtus Inspire Venture Partners. The proceeds will be used to further build the company’s discovery platform and operations.

Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and North Africa
April 12, 2022 Off

Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and North Africa

By Author

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) and Immedica Pharma AB (“Immedica”)have entered a license and supply agreement for Iomab-B, an Antibody Radiation Conjugate comprised of apamistamab, a CD45 targeting antibody, and the radioisotope iodine-131 that is being developed for targeted conditioning to facilitate bone marrow transplant (BMT) and other cell and gene therapies.

List Bio Raises $48.4 Million Series A for Global Scale-Up
April 12, 2022 Off

List Bio Raises $48.4 Million Series A for Global Scale-Up

By Author

List Biotherapeutics, Inc. (List Bio, President: Jonathan Yongwan Jo), a new venture under the Genome and Company umbrella, has announced plans for a new manufacturing facility in the Fishers Life Science & Innovation Park, Indiana after closing their Series A round investment.